Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis
Natalizumab De-escalation With Interferon Beta-1b
|3||Active, not recruiting||
Safety and Effectiveness of Switching Relapsing MS Patients Treated With Natalizumab at Risk for PML to Teriflunomide
† Study has passed its completion date and status has not been verified in more than two years.